Schematic representation of how self-amplifying RNA works. Despite the apparent success of Covid mRNA vaccines, fundamental issues remain. The limitations of the current Pfizer and Moderna vaccines ...
In a recent study published in the journal PLOS Pathogens, researchers in the United States evaluated a novel self-amplifying replicon ribonucleic acid (RNA) vaccine against severe acute respiratory ...
BOSTON, Jan. 14, 2025 /PRNewswire/ -- Keylicon Biosciences is pleased to announce its exclusive rights to a groundbreaking next-generation RNA technology developed at ...
The approval of messenger RNA (mRNA) based COVID-19 vaccines marked a pivotal scientific milestone, establishing mRNA as an innovative drug modality with immense therapeutic potential. However, due to ...
GenScript continues to build on its fast and dependable in vitro transcription RNA synthesis service, offering a new self-amplifying RNA format that enhances the potency and efficacy of vaccines, ...
SAN DIEGO, Nov. 10, 2025 /PRNewswire/ -- Primrose Bio, Inc. ("Primrose"), a company with proprietary therapeutic manufacturing technologies, today announced the launch of Prima RNApols ™ ExTend Cap AU ...
Its growth is attributed to a rise in infectious diseases. The global self-amplifying ribonucleic acid (RNA) synthesis market is projected to reach $310.8m by 2030 at a compound annual growth rate of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback